secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001193125-25-315032
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta exchanges $291M of 1.25% notes due 2027 for 4.875% notes due 2030 plus $31.6M cash
--------------------------------------------------------------------------------

- Exchanges $291.4M principal of 1.25% convertibles due 2027 for same principal of 4.875% convertibles due 2030, plus $31.6M in cash.
- New 4.875% notes are part of same series as $602M issued Aug 2025; post-exchange total $893.4M outstanding.
- Approximately $158.6M of existing 1.25% notes will remain outstanding with unchanged terms.
- Placement agent intends to buy ~691,000 SRPT shares in private transactions from exchanging investors at a discount.
- Exchange expected to close on or about December 18, 2025, subject to customary closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312525315032/0001193125-25-315032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312525315032/d55628d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-315032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer